volver a principal
Teléfonos de información
sobre el Lupus
91 825 11 98 y 674 250 527
Lunes a Viernes
de 09:30 a 13:30
Lunes a Viernes
de 15:00 a 20:00
Quienes somos
Dra. María Galindo Izquierdo
Dra. María Galindo Izquierdo

RESUMEN CURRICULUM



Facultatitva especialista de área en el Hospital 12 de Octubre, Madrid (desde 1998)

Formación académica

Doctora en Medicina y Cirugia por la Universidad Complutense de Madrid (año 2001)

Licenciada en Medicina y Cirugía por la Universidad Complutense de Madrid (año 1993)




Méritos más relevantes (ordenados por tipología)
Publicaciones de artículos científicos
María Pego Reigosa, J.; et al. 2016. Relationship between damage clustering and mortality in systemic lupus erythematosus in early and late stages of the disease: cluster analyses in a large cohort from the Spanish Society of Rheumatology Lupus Registry.Rheumatology (Oxford, England). ISSN 1462-0332.
Galindo-Izquierdo, Maria; et al. 2016. Characterization of Patients With Lupus Nephritis Included in a Large Cohort From the Spanish Society of Rheumatology Registry of Patients With Systemic Lupus Erythematosus (RELESSER).Medicine. RELESSER Group, from the Spanish Society of Rheumatology Systemic Autoimmune Diseases Study Group (EASSER). 95-9, pp.e2891-e2891.
Torrente Segarra, V.; et al. 2015. Fibromyalgia prevalence and related factors in a large registry of patients with systemic lupus erythematosus.Clinical and experimental rheumatology. ISSN 0392-856X.
Urruticoechea-Arana, Ana; et al. 2015. Vitamin D deficiency in chronic inflammatory rheumatic diseases: results of the cardiovascular in rheumatology [CARMA] study. ARTHRITIS RESEARCH & THERAPY. CARMA Project Collaborative Grp. 17. ISSN 1478-6354.
Ines, Luis; et al. 2015. Classification of Systemic Lupus Erythematosus: Systemic Lupus International Collaborating Clinics Versus American College of Rheumatology Criteria. A Comparative Study of 2,055 Patients From a Real-Life, International Systemic Lupus Erythematosus Cohort. ARTHRITIS CARE & RESEARCH. Portuguese Soc Rheumatology Spanish Soc Rheumatology. 67-8, pp.1180-1185. ISSN 2151-464X.
Fernandez-Nebro, Antonio; et al. 2015. Cardiovascular Events in Systemic Lupus Erythematosus A Nationwide Study in Spain From the RELESSER Registry. MEDICINE. Spanish Soc Rheumatology. 94-29. ISSN 0025-7974.
Pego-Reigosa, J. M.; et al. 2015. Analysis of disease activity and response to treatment in a large Spanish cohort of patients with systemic lupus erythematosus. LUPUS. Spanish Soc Rheumatology Systemic. 24-7, pp.720-729. ISSN 0961-2033.
Castañeda, S.; et al. 2015. Cardiovascular morbidity and associated risk factors in Spanish patients with chronic inflammatory rheumatic diseases attending rheumatology clinics: Baseline data of the CARMA Project.Seminars in arthritis and rheumatism. 44-6, pp.618-644. ISSN 1532-866X.
Jimeno, Rebeca; et al. 2015. The pathogenic Th profile of human activated memory Th cells in early rheumatoid arthritis can be modulated by VIP. JOURNAL OF MOLECULAR MEDICINE-JMM. 93-4, pp.457-467. ISSN 0946-2716.
Del Rey, Manuel J; et al. 2015. CD271(+) stromal cells expand in arthritic synovium and exhibit a proinflammatory henotype.Arthritis research & therapy. 18-1, pp.66-66.
Rua-Figueroa, Inigo; et al. 2015. Comprehensive Description of Clinical Characteristics of a Large Systemic Lupus Erythematosus Cohort from the Spanish Rheumatology Society Lupus Registry (RELESSER) With Emphasis on Complete Versus Incomplete Lupus Differences. MEDICINE. Spanish Soc Rheumatology. 94-1. ISSN 0025-7974.
Gonzalo Gil, E.; et al. 2015. Human embryonic stem cell-derived mesenchymal stromal cells ameliorate collagen-induced arthritis by inducing host-derived indoleamine 2,3 dioxygenase.Arthritis research & therapy. 18-1, pp.77. ISSN 1478-6362.
Fernandez-Nebro, A.; et al. 2014. The effects of rituximab on the lipid profile of patients with active systemic lupus erythematosus: results from a nationwide cohort in Spain (LESIMAB). LUPUS. LESIMAB GRP. 23-10, pp.1014-1022. ISSN 0961-2033.
Cuadrado, Maria J.; et al. 2014. Low-dose aspirin vs low-dose aspirin plus low-intensity warfarin in thromboprophylaxis: a prospective, multicentre, randomized, open, controlled trial in patients positive for antiphospholipid antibodies (ALIWAPAS). RHEUMATOLOGY. 53-2, pp.275-284. ISSN 1462-0324.
Rua-Figueroa, Inigo; et al. 2014. National registry of patients with systemic lupus erythematosus of the Spanish Society of Rheumatology: objectives and methodology.Reumatologia clinica. Grupo de trabajo en Enfermedades Autoinmunes Sistemicas de la Sociedad Espanola de Reumatologia (EAS-SER) Unidad de Investigacion de la Sociedad Espanola de Reumatologia (UI-SER). 10-1, pp.17-24.
Portoles-Perez, Jose; et al. 2014. Recommendations for vaccination against pneumococcus in patients with kidney diseases in Spain. NEFROLOGIA. 34-5, pp.545-551. ISSN 0211-6995.
Gonzalo-Gil, Elena; Galindo-Izquierdo, Maria. 2014. Role of transforming growth factor-beta (TGF) beta in the physiopathology of rheumatoid arthritis.Reumatologia clinica. 10-3, pp.174-9.
Gonzalo-Gil, E.; et al. 2013. Transforming growth factor (TGF)-beta signalling is increased in rheumatoid synovium but TGF-beta blockade does not modify experimental arthritis. CLINICAL AND EXPERIMENTAL IMMUNOLOGY. 174-2, pp.245-255. ISSN 0009-9104.
Jose Picazo, Juan; et al. 2013. Consenso sobre la vacunacion anti-neumococica en el adulto con patologia de base. REVISTA ESPANOLA DE QUIMIOTERAPIA. 26-3, pp.232-252. ISSN 0214-3429.
Calvo-Alen, Jaime; et al. 2013. SER consensus statement on the use of biologic therapy for systemic lupus erythematosus.Reumatologia clinica. Sociedad Española de Reumatologia. 9-5, pp.281-96.
Gomez-Reino, Juan J.; et al. 2012. Comparative effectiveness of switching to alternative tumour necrosis factor (TNF) antagonists versus switching to rituximab in patients with rheumatoid arthritis who failed previous TNF antagonists: the MIRAR Study. ANNALS OF THE RHEUMATIC DISEASES. MIRAR Study Grp. 71-11, pp.1861-1864. ISSN 0003-4967.
Fernandez-Nebro, A.; et al. 2012. Multicenter longitudinal study of B-lymphocyte depletion in refractory systemic lupus erythematosus: the LESIMAB study. LUPUS. 21-10, pp.1063-1076. ISSN 0961-2033.
Gonzalo, Elena; et al. 2012. Clinicopathologic correlations of renal microthrombosis and inflammatory markers in proliferative lupus nephritis. ARTHRITIS RESEARCH & THERAPY. 14-3. ISSN 1478-6354.
Del Olmo, L; et al. 2012. [Peri-operative management of disease modifying anti-rheumatic drugs: recommendations based on a meta-analysis].Revista española de cirugia ortopedica y traumatologia. 56-5, pp.393-412.
Carmona, Loreto; et al. 2011. Cancer in Patients with Rheumatic Diseases Exposed to TNF Antagonists. SEMINARS IN ARTHRITIS AND RHEUMATISM. BIOBADASER Study Grp EMECAR Study Grp. 41-1, pp.71-80. ISSN 0049-0172.
Santiago, Begona; et al. 2011. CXCL12 gene expression is upregulated by hypoxia and growth arrest but not by inflammatory cytokines in rheumatoid synovial fibroblasts. CYTOKINE. 53-2, pp.184-190. ISSN 1043-4666.
María Galindo Izquierdo; José Luis Pablos Alvarez. 2011. Reactantes de fase aguda: valor diagnóstico y pronóstico en la artritis reumatoide. Rheumatology Updates, actualizaciones en artritis reumatoide. Publicaciones Permanyer. 1, pp.5-9.
del Rey, Manuel J.; et al. 2009. Human Inflammatory Synovial Fibroblasts Induce Enhanced Myeloid Cell Recruitment and Angiogenesis Through a Hypoxia-Inducible Transcription Factor 1 alpha/Vascular Endothelial Growth Factor-Mediated Pathway in Immunodeficient Mice. ARTHRITIS AND RHEUMATISM. 60-10, pp.2926-2934. ISSN 0004-3591.
Galindo, Maria; et al. 2009. Immunohistochemical detection of intravascular platelet microthrombi in patients with lupus nephritis and anti-phospholipid antibodies. RHEUMATOLOGY. 48-8, pp.1003-1007. ISSN 1462-0324.
Pena-Sagredo, J. L.; et al. 2009. Non-typhi Salmonella infection in patients with rheumatic diseases on TNF-alpha antagonist therapy. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. BIOBADASER Grp EMECAR Grp. 27-6, pp.920-925. ISSN 0392-856X.
Abásolo, L.; et al. 2008. Cancer in rheumatoid arthritis: occurrence, mortality, and associated factors in a South European population.Seminars in arthritis and rheumatism. 37-6, pp.388-485. ISSN 0049-0172.
Paya, Monica; et al. 2006. Optimising stable retroviral transduction of primary human synovial fibroblasts. JOURNAL OF VIROLOGICAL METHODS. 137-1, pp.95-102. ISSN 0166-0934.
Joven, BE; et al. 2006. Does anti-tumour necrosis factor alpha treatment modify the tuberculin PPD response?. ANNALS OF THE RHEUMATIC DISEASES. 65-5, pp.699-699. ISSN 0003-4967.
Palao, G; et al. 2006. Fas activation of a proinflammatory program in rheumatoid synoviocytes and its regulation by FLIP and caspase 8 signaling. ARTHRITIS AND RHEUMATISM. 54-5, pp.1473-1481. ISSN 0004-3591.
Torres, C; et al. 2006. Survival, mortality and causes of death in inflammatory myopathies. AUTOIMMUNITY. 39-3, pp.205-215. ISSN 0891-6934.
Gutierrez-Canas, I; et al. 2006. VIP down-regulates TLR4 expression and TLR4-mediated chemokine production in human rheumatoid synovial fibroblasts. RHEUMATOLOGY. 45-5, pp.527-532. ISSN 1462-0324.

Publicaciones de capítulos en libro
María Galindo Izquierdo; et al. 2016. Biomarkers of Renal Microthrombosis in Lupus Nephritis. Biomarkers in Kidney Disease. Springer Netherlands. pp.1-19.
2014. Tratamiento de las cipolinas asociadas al lupus eritematoso sistémico. Manual SER de diagnóstico y tratamiento de las enfermedades reumáticas autoinmunes sistémicas.Elsevier. 19, pp.113-117. ISBN 978-84-9022-857-9.
Loreto Carmona Ortells; María Galindo Izquierdo. 2013. Perioperative Management of Immunesuppression. Oxford Textbook of Rheumatology 4e. Oxford University Press; Oxford. 93.
María Galindo Izquierdo. 2008. Lupus Eritematoso Sistémico. Manual SER de las Enfermedades Reumáticas. 5ª Edición.Editorial Médica Panamericana. 32, pp.235-247. ISBN 978-84-9835-105-7.
María Galindo Izquierdo; José Luis Pablos Alvarez. 2007. Dinámica celular en el tejido inflamatorio crónico: proliferación, apoptosis, angiogénesis. Monografías SER. Técnicas en Investigación Básica en Reumatología.Editorial Médica Panamericana.. pp.119-132. ISBN 978-84-7903-908-6.
María Galindo Izquierdo. 2007. Retrovirus endógenos y autoinmunidad. Monografías SER. Artritis Infecciosas.Editorial Médica Panamericana. pp.193-207. ISBN 978-84-9835-145-3.

Publicaciones de libros o monografías científicas
2015. Guía de Práctica Clínica sobre Lupus Eritematoso Sistémico del Ministerio de Sanidad, Servicios Sociales e Igualdad.Guías de Práctica Clínica del SNS. Guías de Práctica Clínica del SNS.
Rúa Figueroa, I.; et al. 2016. Comorbidities in patients with Primary Sjögren's Syndrome and Systemic Lupus Erythematosus: A comparative registries-based study.Arthritis care & research. ISSN 2151-4658.
Martínez López, JA.; et al. 2016. Recommendations for the evaluation and management of patients with rheumatic autoimmune and inflammatory diseases during the reproductive age, pregnancy, postpartum and breastfeeding.Reumatologia clinica. ISSN 1885-1398.
Gonzalo Gil, E.; et al. 2015. Human embryonic stem cell-derived mesenchymal stromal cells ameliorate collagen-induced arthritis by inducing host-derived indoleamine 2,3 dioxygenase.Arthritis research & therapy. 18, pp.77. ISSN 1478-6362.